Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akoya Biosciences, Inc.

1.68
+0.05503.40%
Volume:50.48K
Turnover:84.23K
Market Cap:83.44M
PE:-1.50
High:1.73
Open:1.60
Low:1.60
Close:1.62
Loading ...

Quanterix Corp - Akoya Shareholders to Receive 0.318 Shares of Quanterix Stock per Share

THOMSON REUTERS
·
10 Jan

Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers

THOMSON REUTERS
·
10 Jan

Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers

Business Wire
·
10 Jan

BRIEF-Quanterix Is Close To All-Stock Deal For Akoya Bioscience - Bloomberg News

Reuters
·
10 Jan

Quanterix Is Close to All-Stock Deal for Akoya Bioscience - Bloomberg News

THOMSON REUTERS
·
10 Jan

Akoya Biosciences Secures Exclusive License for NeraCare's Immunoprint Test

MT Newswires Live
·
10 Dec 2024

Akoya Biosciences and Neracare Enter Into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions

THOMSON REUTERS
·
10 Dec 2024

Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions

GlobeNewswire
·
10 Dec 2024

Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone

GlobeNewswire
·
09 Dec 2024

Akoya Biosciences Price Target Cut to $3.00/Share From $4.00 by Piper Sandler

Dow Jones
·
20 Nov 2024

Akoya Biosciences price target lowered to $3 from $4 at Piper Sandler

TIPRANKS
·
19 Nov 2024

Time To Worry? Analysts Just Downgraded Their Akoya Biosciences, Inc. (NASDAQ:AKYA) Outlook

Simply Wall St.
·
17 Nov 2024

Akoya Biosciences Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.
·
16 Nov 2024

Akoya Biosciences Cut to Hold From Buy by Craig-Hallum

Dow Jones
·
16 Nov 2024

Akoya Biosciences Shares Down 26.2% on Slashing Annual Revenue Forecast

THOMSON REUTERS
·
15 Nov 2024

Akoya Biosciences Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
15 Nov 2024